Inotuzumab Ozogamicin for Children With MRD Positive CD22+ Lymphoblastic Leukemia
St. Jude Children's Research Hospital
St. Jude Children's Research Hospital
OHSU Knight Cancer Institute
Sun Yat-sen University
Stanford University
M.D. Anderson Cancer Center
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Northwestern University
Stanford University
Stanford University
St. Jude Children's Research Hospital
Masonic Cancer Center, University of Minnesota
Masonic Cancer Center, University of Minnesota
Masonic Cancer Center, University of Minnesota
OHSU Knight Cancer Institute
French Innovative Leukemia Organisation
UNICANCER
Vanderbilt-Ingram Cancer Center
Istituto Clinico Humanitas
Medical College of Wisconsin
H. Lee Moffitt Cancer Center and Research Institute
H. Lee Moffitt Cancer Center and Research Institute
Keio University